DarioHealth (DRIO) Competitor Comparison
We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.
Market Capitalization
48 / 58Gross Profits
46 / 52Total Revenue
48 / 57EBITDA
47 / 56Free Cashflow
38 / 56Quick Ratio
6 / 57Earnings per Share
43 / 57Dividend yield
0 / 8Total Cash
41 / 57Performance 3 years
54 / 58Performance 5 years
17 / 58Performance 10 years
42 / 58Linearity 3 years
46 / 58Linearity 5 years
4 / 58Linearity 10 years
11 / 58Total Rank
40 / 58Dividend Rank
46 / 58Valuation Rank
12 / 58Piotroski Rank
27 / 58Muliplier Rank
43 / 58Piotroski Rank - DRIO ranking 27 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.